Kochegarov Andrei
University of California Riverside, Department of Chemistry, Physical Science Unit 1, Riverside, CA 92521-0403, USA.
Expert Opin Ther Pat. 2009 Mar;19(3):275-81. doi: 10.1517/13543770802709010.
Embryonic stem cells are pluripotent cells that can differentiate to any cell type. Stem-cell research promises great progress in regenerative medicine to replace damaged tissues and organs.
There are two key scientific questions: i) what causes stem cells to maintain an undifferentiated state; and ii) what signals affect/initiate differentiation? Understanding molecular mechanisms and signals that determine stem cell fate, either differentiation or proliferation, will significantly promote the realization of therapeutic potential of stem cells.
There are several ways to differentiate stem cells. This review focuses on a chemical approach of differentiation and nuclear reprogramming by small molecules.
The effects on different signaling pathways, such as Wnt, IP-3K/Akt, and mitogen-activated protein kinase, of small-molecule modulators may direct differentiation of stem cells to different tissues or keep them undifferentiated and pluripotent. Within the last few years, reports of successful screening of small molecules, such as dcAMP, BIO, pluripotin, and others, have been published.
胚胎干细胞是能够分化为任何细胞类型的多能干细胞。干细胞研究有望在再生医学领域取得巨大进展,以替代受损的组织和器官。
存在两个关键的科学问题:i)是什么导致干细胞维持未分化状态;ii)哪些信号影响/启动分化?了解决定干细胞命运(分化或增殖)的分子机制和信号,将显著促进干细胞治疗潜力的实现。
有多种使干细胞分化的方法。本综述重点关注通过小分子进行分化和核重编程的化学方法。
小分子调节剂对不同信号通路(如Wnt、IP-3K/Akt和丝裂原活化蛋白激酶)的影响,可能会引导干细胞分化为不同组织,或使其保持未分化和多能状态。在过去几年中,已发表了成功筛选小分子(如dcAMP、BIO、pluripotin等)的报告。